Pitcairn Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Pitcairn Wealth Advisors's LLY Position: Q2 2026 in Review
Pitcairn Wealth Advisors increased its Eli Lilly (LLY) stake by 5.6% in Q2 2026, buying an estimated $180K and bringing the position to 3,293 shares worth $3.95M. The position accounts for 0.43% of the portfolio, ranked #36.
Pitcairn Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.21M in Q4 2025. 4,612 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Pitcairn Wealth Advisors held 3,293 shares of Eli Lilly worth $3.95M as of Q2 2026.
- Pitcairn Wealth Advisors bought 176 Eli Lilly shares in Q2 2026, an estimated $180K.
- Eli Lilly made up 0.43% of Pitcairn Wealth Advisors's portfolio in Q2 2026, its #36 holding.
- Pitcairn Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- Pitcairn Wealth Advisors's Eli Lilly position peaked at $4.21M in Q4 2025.
- 4,612 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Pitcairn Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.